Vaccine maker stocks fall as Trump chooses RFK Jr. to lead HHS
Shares of vaccine makers fell as President-elect Donald Trump nominated Robert F. Kennedy Jr., a prominent vaccine skeptic, to lead the Department of Health and Human Services. Health policy experts have said a second Trump term could allow Kennedy to elevate anti-vaccine rhetoric.
GSK on Wednesday said its vaccine sales would fall this year, after a weaker-than-expected performance for its respiratory ...
The print ads featured a prominent display of a person’s back, highlighting where shingles rashes typically emerge.
News Medical on MSN10h
Study shows RSV’s severe impact on US adults, urging more testing and vaccinationRSV hospitalizations in US adults reached high levels pre-vaccine, especially impacting those 75 and older, underscoring the ...
GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...
Under deal terms, GSK will give Vesalius Therapeutics $80 million in upfront and equity payments to identify treatments for ...
Respiratory syncytial virus (RSV) caused significant hospitalizations and severe outcomes in adults, especially those aged 75 ...
Medpage Today on MSN3d
Which High-Risk Patients Should Get the RSV Vaccine?The CDC recommends a single dose of any FDA-approved respiratory syncytial virus (RSV) vaccine for all adults ages 75 years ...
7hon MSN
Get the latest news on the transition to the new administration of President-elect Donald Trump and a new Congress.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback